KEAP1 and melanoma: However, we can certainly exclude the intervention of post-translational mechanisms leading to a decrease in KEAP1 content, such as the p62 Nrf2-KEAP2 disruptor, or the dysregulation of microRNA targeting KEAP1, since the KEAP1 protein content remains unchanged in all melanoma clones studied here.